NATIXIS ADVISORS, L.P. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 112 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 1.0%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$200
-6.1%
87,425
-0.1%
0.00%0.0%
Q1 2023$213
-99.9%
87,505
-1.0%
0.00%0.0%
Q3 2022$212,000
-42.7%
88,411
-5.9%
0.00%0.0%
Q4 2021$370,000
-18.7%
93,969
-0.6%
0.00%
-50.0%
Q3 2021$455,000
+4.6%
94,537
-0.2%
0.00%0.0%
Q2 2021$435,000
-21.8%
94,745
-0.1%
0.00%
-33.3%
Q1 2021$556,000
+61.2%
94,859
-6.1%
0.00%
+50.0%
Q4 2020$345,000100,9930.00%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Artal Group S.A. 71,178,364$280,443,0007.61%
BVF INC/IL 14,360,000$56,578,0002.05%
Integral Health Asset Management, LLC 200,000$788,0000.22%
Eversept Partners, LP 797,694$3,142,9140.20%
NEA Management Company, LLC 2,382,286$9,386,0000.19%
PINNACLE ASSOCIATES LTD 2,127,662$8,383,0000.14%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$141,0000.06%
Virtus ETF Advisers LLC 41,584$164,0000.06%
Pegasus Asset Management, Inc. 10,000$39,0000.02%
GSA CAPITAL PARTNERS LLP 31,562$124,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders